ResearcherSeoul National UniversityActive in the last 2 years
Sang Kook Lee
Matched on ORCID iD 0000-0002-4306-7024; OpenAlex author ID A5033086793, A5159726396. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 18
2022: 1 paper · 2023: 2 papers · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper
Papers 7
- Metabologenomic Hallmark-Based Discovery of Bacterial Thioamides as a New Lead against Drug-Resistant Pancreatic Cancer. Co-author DOI 10.1002/advs.202517849↗
- Targeting HASPIN in gemcitabine-resistant pancreatic cancer cells by lead optimization of thioadenosine analogue. Co-author DOI 10.1016/j.biopha.2025.118135↗
- Evo312: An Evodiamine Analog and Novel PKCβI Inhibitor with Potent Antitumor Activity in Gemcitabine-Resistant Pancreatic Cancer. Last author DOI 10.1021/acs.jmedchem.4c00213↗
- Antiproliferative Activity of Piceamycin by Regulating Alpha-Actinin-4 in Gemcitabine-Resistant Pancreatic Cancer Cells. Last author DOI 10.4062/biomolther.2023.109↗
- Periplocin exerts antitumor activity by regulating Nrf2-mediated signaling pathway in gemcitabine-resistant pancreatic cancer cells. Last author DOI 10.1016/j.biopha.2022.114039↗
- Antiproliferative Activity of Krukovine by Regulating Transmembrane Protein 139 (TMEM139) in Oxaliplatin-Resistant Pancreatic Cancer Cells. Co-author DOI 10.3390/cancers15092642↗
- Establishment of Patient-Derived Pancreatic Cancer Organoids from Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsies. Co-author DOI 10.5009/gnl210166↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Eun Seo Bae · 4 shared papers, 2023–2026 · strength 0.92
- Paper Evo312: An Evodiamine Analog and Novel PKCβI Inhibitor with Potent Antitumor Activity in Gemcitabine-Resistant Pancreat… DOI 10.1021/acs.jmedchem.4c00213↗
- Paper Metabologenomic Hallmark-Based Discovery of Bacterial Thioamides as a New Lead against Drug-Resistant Pancreatic Cancer. DOI 10.1002/advs.202517849↗
- Paper Targeting HASPIN in gemcitabine-resistant pancreatic cancer cells by lead optimization of thioadenosine analogue. DOI 10.1016/j.biopha.2025.118135↗
- J.H. Lee · 3 shared papers, 2022–2024 · strength 0.48
- Paper Antiproliferative Activity of Piceamycin by Regulating Alpha-Actinin-4 in Gemcitabine-Resistant Pancreatic Cancer Cells. DOI 10.4062/biomolther.2023.109↗
- Paper Antiproliferative Activity of Krukovine by Regulating Transmembrane Protein 139 (TMEM139) in Oxaliplatin-Resistant Panc… DOI 10.3390/cancers15092642↗
- Paper Establishment of Patient-Derived Pancreatic Cancer Organoids from Endoscopic Ultrasound-Guided Fine-Needle Aspiration B… DOI 10.5009/gnl210166↗
- Ja‐Lok Ku · 3 shared papers, 2022–2024 · strength 0.48
- Paper Antiproliferative Activity of Piceamycin by Regulating Alpha-Actinin-4 in Gemcitabine-Resistant Pancreatic Cancer Cells. DOI 10.4062/biomolther.2023.109↗
- Paper Antiproliferative Activity of Krukovine by Regulating Transmembrane Protein 139 (TMEM139) in Oxaliplatin-Resistant Panc… DOI 10.3390/cancers15092642↗
- Paper Establishment of Patient-Derived Pancreatic Cancer Organoids from Endoscopic Ultrasound-Guided Fine-Needle Aspiration B… DOI 10.5009/gnl210166↗
- Sang Hyub Lee · 3 shared papers, 2022–2024 · strength 0.48
- Paper Antiproliferative Activity of Piceamycin by Regulating Alpha-Actinin-4 in Gemcitabine-Resistant Pancreatic Cancer Cells. DOI 10.4062/biomolther.2023.109↗
- Paper Antiproliferative Activity of Krukovine by Regulating Transmembrane Protein 139 (TMEM139) in Oxaliplatin-Resistant Panc… DOI 10.3390/cancers15092642↗
- Paper Establishment of Patient-Derived Pancreatic Cancer Organoids from Endoscopic Ultrasound-Guided Fine-Needle Aspiration B… DOI 10.5009/gnl210166↗
- Ji Kon Ryu · 3 shared papers, 2022–2024 · strength 0.48
- Paper Antiproliferative Activity of Piceamycin by Regulating Alpha-Actinin-4 in Gemcitabine-Resistant Pancreatic Cancer Cells. DOI 10.4062/biomolther.2023.109↗
- Paper Antiproliferative Activity of Krukovine by Regulating Transmembrane Protein 139 (TMEM139) in Oxaliplatin-Resistant Panc… DOI 10.3390/cancers15092642↗
- Paper Establishment of Patient-Derived Pancreatic Cancer Organoids from Endoscopic Ultrasound-Guided Fine-Needle Aspiration B… DOI 10.5009/gnl210166↗
- Yong‐Tae Kim · 3 shared papers, 2022–2024 · strength 0.48
- Paper Antiproliferative Activity of Piceamycin by Regulating Alpha-Actinin-4 in Gemcitabine-Resistant Pancreatic Cancer Cells. DOI 10.4062/biomolther.2023.109↗
- Paper Antiproliferative Activity of Krukovine by Regulating Transmembrane Protein 139 (TMEM139) in Oxaliplatin-Resistant Panc… DOI 10.3390/cancers15092642↗
- Paper Establishment of Patient-Derived Pancreatic Cancer Organoids from Endoscopic Ultrasound-Guided Fine-Needle Aspiration B… DOI 10.5009/gnl210166↗
- Dong‐Chan Oh · 2 shared papers, 2024–2026 · strength 0.42
- Paper Metabologenomic Hallmark-Based Discovery of Bacterial Thioamides as a New Lead against Drug-Resistant Pancreatic Cancer. DOI 10.1002/advs.202517849↗
- Paper Antiproliferative Activity of Piceamycin by Regulating Alpha-Actinin-4 in Gemcitabine-Resistant Pancreatic Cancer Cells. DOI 10.4062/biomolther.2023.109↗
- Jin Ho Choi MD · 2 shared papers, 2023–2024 · strength 0.34
- Paper Antiproliferative Activity of Piceamycin by Regulating Alpha-Actinin-4 in Gemcitabine-Resistant Pancreatic Cancer Cells. DOI 10.4062/biomolther.2023.109↗
- Paper Antiproliferative Activity of Krukovine by Regulating Transmembrane Protein 139 (TMEM139) in Oxaliplatin-Resistant Panc… DOI 10.3390/cancers15092642↗
- Min Woo Lee · 2 shared papers, 2023–2024 · strength 0.34
- Paper Antiproliferative Activity of Piceamycin by Regulating Alpha-Actinin-4 in Gemcitabine-Resistant Pancreatic Cancer Cells. DOI 10.4062/biomolther.2023.109↗
- Paper Antiproliferative Activity of Krukovine by Regulating Transmembrane Protein 139 (TMEM139) in Oxaliplatin-Resistant Panc… DOI 10.3390/cancers15092642↗
- Woo Hyun Paik · 2 shared papers, 2022–2024 · strength 0.33
- Paper Antiproliferative Activity of Piceamycin by Regulating Alpha-Actinin-4 in Gemcitabine-Resistant Pancreatic Cancer Cells. DOI 10.4062/biomolther.2023.109↗
- Paper Establishment of Patient-Derived Pancreatic Cancer Organoids from Endoscopic Ultrasound-Guided Fine-Needle Aspiration B… DOI 10.5009/gnl210166↗
- Young Eun Du · 1 shared paper, 2026 · strength 0.23
- Hyuk‐Jin Cha · 1 shared paper, 2025 · strength 0.23
- Yoon-Ze Shin · 1 shared paper, 2025 · strength 0.23
- In Rae Cho · 1 shared paper, 2024 · strength 0.18
- Haeryoung Kim · 1 shared paper, 2022 · strength 0.14
- Soon‐Chan Kim · 1 shared paper, 2022 · strength 0.14
- Jung Won Chun · 1 shared paper, 2022 · strength 0.14
- Andrew M. Lowy · 1 shared paper, 2022 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.